Future work will focus on identifying the precise binding sites of these derivatives on Gli1 and evaluating their effects on key mechanisms of tumor cell proliferation, particularly in cancers with aberrant HH signaling, such as medulloblastoma or rhabdomyosarcoma. Here, GLI1 is linked to cancer.